Target intelligence / Profile preview

Cell surface carbohydrate moiety

Molecular classification
Other (Glycan moieties; components of glycoproteins and glycolipids, not a receptor, enzyme, or transporter themselves)
01

Overview

Cell surface carbohydrate moieties are diverse sugar chains covalently attached to glycoproteins and glycolipids present on the outer leaflet of the plasma membrane. These structures play crucial roles in cell-cell recognition, adhesion, and signaling by serving as binding sites for lectins (carbohydrate-binding proteins) and other cell-surface receptors. They are involved in physiological processes such as immune surveillance, inflammation, fertilization, and pathogen attachment. The composition and spatial organization of these carbohydrates contribute to the creation of functional cell surface microdomains, influence interactions with extracellular matrix proteins, and modulate cellular responses in health and disease. Aberrant expression or modification of cell surface carbohydrates is associated with pathological processes, including tumor progression and immune evasion[4][3][1][5]. There is no single canonical receptor or gene product defined by the term "carbohydrate moiety on cell surface"; instead, it designates a structural motif found in many molecular families. For therapeutic targeting or drug discovery, identification of a specific glycoprotein, glycolipid, or carbohydrate epitope is necessary.

Other names
Cell surface carbohydratesSurface glycansCell surface glycanCarbohydrate chain on plasma membrane
02

Biological functions

Cell adhesion and recognitionImmune response modulationSignal transduction (via interaction with lectins and cell-surface proteins)Pathogen binding and infectionFertilization (e.g., sperm-egg recognition)Cell migration and lymphocyte homing
03

Disease associations

Cancer (altered cell surface carbohydrates in malignancy/metastasis)Infection (pathogen entry via glycan recognition)Immune-mediated diseasesOther (including inflammation, developmental disorders)
04

Biomarkers

Altered glycan patterns can serve as cancer biomarkers (e.g., sialic acid-rich glycans in tumors), but not universally for all carbohydrate moieties

Beyond the preview

Go deeper on Cell surface carbohydrate moiety.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell surface carbohydrate moiety.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call